Harbinger Health
Founded 2021 · 64 employees on LinkedIn · 4 known investors
Harbinger Health develops early cancer detection technology through its Harbinger HX platform, which embeds developmental biology into biomarker discovery, assay design, and model training to detect faint biological signals of early cancer in real-world samples. The company builds tools for oncology and cancer management.
Investors · 4
Also in the syndicate · 2
Partners InvestmentPictet
Funding
SEC filings, press & company announcements$240M disclosed across 2 rounds · 2023–2026
- $100MraisedApr 2026 · 2 sources
Flagship Pioneering (lead)
Source ↗ - $140MSeries BSep 2023 · 3 sources
Catalyst, Flagship Pioneering, Partners Investment, Pictet
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Harbinger Health do?
- Harbinger Health develops early cancer detection technology through its Harbinger HX platform, which embeds developmental biology into biomarker discovery, assay design, and model training to detect faint biological signals of early cancer in real-world samples. The company builds tools for oncology and cancer management.
- Who are Harbinger Health's investors?
- Harbinger Health's investors include Flagship Pioneering, Catalyst.
- How much funding has Harbinger Health raised?
- Harbinger Health has disclosed $240M raised across 2 rounds.